Tatsuta T, Hosono M
Glycoconj J. 2022; 39(2):157-165.
PMID: 35066741
DOI: 10.1007/s10719-021-10033-9.
Garnett E, Raines R
Crit Rev Biochem Mol Biol. 2021; 57(3):244-260.
PMID: 34886717
PMC: 9156540.
DOI: 10.1080/10409238.2021.2004577.
Catanzaro E, Calcabrini C, Bishayee A, Fimognari C
Mar Drugs. 2019; 18(1).
PMID: 31877692
PMC: 7024344.
DOI: 10.3390/md18010011.
Prats-Ejarque G, Lu L, Salazar V, Moussaoui M, Boix E
Front Pharmacol. 2019; 10:1170.
PMID: 31649540
PMC: 6794472.
DOI: 10.3389/fphar.2019.01170.
Tatsuta T, Satoh T, Sugawara S, Hara A, Hosono M
PLoS One. 2018; 13(1):e0190653.
PMID: 29298350
PMC: 5752036.
DOI: 10.1371/journal.pone.0190653.
A study of ribonuclease activity in venom of vietnam cobra.
Nguyen T, Osipov A
J Anim Sci Technol. 2017; 59:20.
PMID: 29021904
PMC: 5611641.
DOI: 10.1186/s40781-017-0145-5.
Cancer-selective induction of apoptosis by leczyme.
Tatsuta T, Sugawara S, Takahashi K, Ogawa Y, Hosono M, Nitta K
Front Oncol. 2014; 4:139.
PMID: 24926439
PMC: 4044787.
DOI: 10.3389/fonc.2014.00139.
Leczyme: a new candidate drug for cancer therapy.
Tatsuta T, Sugawara S, Takahashi K, Ogawa Y, Hosono M, Nitta K
Biomed Res Int. 2014; 2014:421415.
PMID: 24864241
PMC: 4017849.
DOI: 10.1155/2014/421415.
Letter to the Editor: Sequence-specific 1H, 13C and 15N resonance assignments of recombinant onconase/P-30 protein.
Gorbatyuk V, Chen Y, Wu Y, Youle R, Huang T
J Biomol NMR. 2010; 15(4):343-4.
PMID: 20703857
DOI: 10.1023/A:1008312325225.
Ranpirnase and its potential for the treatment of unresectable malignant mesothelioma.
Porta C, Paglino C, Mutti L
Biologics. 2009; 2(4):601-9.
PMID: 19707441
PMC: 2727885.
DOI: 10.2147/btt.s2383.
Oxidative folding and N-terminal cyclization of onconase.
Welker E, Hathaway L, Xu G, Narayan M, Pradeep L, Shin H
Biochemistry. 2007; 46(18):5485-93.
PMID: 17439243
PMC: 2535829.
DOI: 10.1021/bi602495a.
Isothermal titration calorimetric study of RNase-A kinetics (cCMP --> 3'-CMP) involving end-product inhibition.
Spencer S, Raffa R
Pharm Res. 2004; 21(9):1642-7.
PMID: 15497691
DOI: 10.1023/b:pham.0000041460.78128.0f.
Oligomerization of bovine ribonuclease A: structural and functional features of its multimers.
Libonati M, Gotte G
Biochem J. 2004; 380(Pt 2):311-27.
PMID: 15104538
PMC: 1224197.
DOI: 10.1042/BJ20031922.
The structural integrity exerted by N-terminal pyroglutamate is crucial for the cytotoxicity of frog ribonuclease from Rana pipiens.
Liao Y, Wang S, Leu Y, Wang C, Chang S, Hong Y
Nucleic Acids Res. 2003; 31(18):5247-55.
PMID: 12954760
PMC: 203329.
DOI: 10.1093/nar/gkg746.
Secretory ribonucleases are internalized by a dynamin-independent endocytic pathway.
Haigis M, Raines R
J Cell Sci. 2002; 116(Pt 2):313-24.
PMID: 12482917
PMC: 2812863.
DOI: 10.1242/jcs.00214.
Regulation of ribonuclease expression by estradiol in Rana catesbeiana (Bullfrog).
Tang P, Huang H, Wang S, Jeng J, Liao Y
Nucleic Acids Res. 2002; 30(14):3286-93.
PMID: 12136111
PMC: 135762.
DOI: 10.1093/nar/gkf442.
Cancer chemotherapy--ribonucleases to the rescue.
Leland P, Raines R
Chem Biol. 2001; 8(5):405-13.
PMID: 11358688
PMC: 2913432.
DOI: 10.1016/s1074-5521(01)00030-8.
Characterization of Rny1, the Saccharomyces cerevisiae member of the T2 RNase family of RNases: unexpected functions for ancient enzymes?.
MacIntosh G, Bariola P, Newbigin E, Green P
Proc Natl Acad Sci U S A. 2001; 98(3):1018-23.
PMID: 11158587
PMC: 14701.
DOI: 10.1073/pnas.98.3.1018.
Purification and cloning of cytotoxic ribonucleases from Rana catesbeiana (bullfrog).
Liao Y, Huang H, Leu Y, Wei C, Tang P, Wang S
Nucleic Acids Res. 2000; 28(21):4097-104.
PMID: 11058105
PMC: 113159.
DOI: 10.1093/nar/28.21.4097.